This would have to be the biggest bargain! with a market cap of 17+ million the fundamentals are not refelecting this and according to Valutech Biotech yesterday there "are high expectations for this company". With the most recent update we cannot help but get very excited indeed. This little ripper will shine over the next few months and then be down right glaring this time next year when sales of the Wheezometer are established and branded. Not to mention the other 2 great components of the "tripod"..
We now have with us Bill Nicklin who will work within the current manufacturing team. Bill was the founding VP of Manufacturing at ResMed, "Bill has vast experience and standing as a manufacturing and quality control expert with more than 20 years of proven track record of transitioning prototypes to globally successful products in the biomedical device arena."
Cuurent update....
"Clinical validation of our value proposition KSX has atrue first mover advantage in the $30B global market space for asthma. This means that we can navigate this market space with little initial competition. However, this first mover advantage also results in the fundamental challenge of needing to educate the end users of our value proposition and more specifically,how the medical professionals and patients can benefit from our offerings. We plan to make KarmelSonix a branded name synonymous with asthma related diagnostics, monitoring and management. To accomplish this, we plan to expand our current clinical site partners to ten world class sites. we will implement our transformation plans that should enable the Company to emerge as a credible global solutions provider in the multibillion dollar market of asthma monitoring and management. Thank you for continued interest in and support for KarmelSonix. I look forward to bringing you further updates in the coming weeks. Yours sincerely, Ross Haghighat Director and Interim CEO Dated: 9th November 2010 For additional information please contact: Mr. Ross Haghighat, Director & Interim CEO + 1 978 375 0085 [email protected] Mr. Paul Eisen, KarmelSonix Managing +61(0) 417069887 [email protected] Director Europe
KSX Price at posting:
2.6¢ Sentiment: LT Buy Disclosure: Held